|
MBLAC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.29050001188114E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.9650000232806E-09 |
| Normal-vs-Stage2 |
3.81110000000628E-05 |
| Normal-vs-Stage3 |
2.109800E-02 |
| Normal-vs-Stage4 |
3.336600E-01 |
| Stage1-vs-Stage2 |
5.099800E-01 |
| Stage1-vs-Stage3 |
8.107600E-02 |
| Stage1-vs-Stage4 |
2.031800E-01 |
| Stage2-vs-Stage3 |
3.017800E-01 |
| Stage2-vs-Stage4 |
3.383400E-01 |
| Stage3-vs-Stage4 |
7.188800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06130004784433E-09 |
| Normal-vs-AfricanAmerican |
1.60979999996869E-07 |
| Normal-vs-Asian |
6.155400E-01 |
| Caucasian-vs-AfricanAmerican |
9.004600E-01 |
| Caucasian-vs-Asian |
3.419200E-01 |
| AfricanAmerican-vs-Asian |
3.575800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.5069001602086E-10 |
| Normal-vs-Female |
4.23539999999667E-05 |
| Male-vs-Female |
4.215300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.446910E-04 |
| Normal-vs-Extreme_Weight |
1.93559945849131E-10 |
| Normal-vs-Obese |
9.5445000003469E-07 |
| Normal-vs-Extreme_Obese |
5.63569999999514E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.885600E-01 |
| Normal_Weight-vs-Obese |
8.182600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.650400E-01 |
| Extreme_Weight-vs-Obese |
1.228630E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.943200E-01 |
| Obese-vs-Extreme_Obese |
5.950200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.30780000000097E-05 |
| Normal-vs-Age(41-60Yrs) |
2.65199999960331E-07 |
| Normal-vs-Age(61-80Yrs) |
3.05049985271921E-10 |
| Normal-vs-Age(81-100Yrs) |
1.94182999999626E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.567800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.625400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.903400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.064000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.144600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.361600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.67799107941846E-12 |
| Normal-VS-Type2 PRCC |
5.402900E-04 |
| Normal-VS-KIRP CIMP |
2.36999999999599E-05 |
| Normal-VS-Unclassified PRCC |
2.152100E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.557600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
8.606400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.962440E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.282400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.695000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.336800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.84220000001945E-06 |
| Normal-vs-N1 |
1.659950E-02 |
| Normal-vs-N2 |
3.033300E-04 |
| N0-vs-N1 |
2.733400E-01 |
| N0-vs-N2 |
4.315600E-01 |
| N1-vs-N2 |
2.067200E-01 |
|
|
